Lifeward (LFWD) Stock Price, News & Analysis

Company Overview

ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in the United States, Europe, the Asia-Pacific, and internationally. It offers ReWalk personal exoskeleton and rehabilitation exoskeleton devices; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke; AlterG Anti-Gravity System for use in physical and neurological rehabilitation and athletic training; MyoCycle devices; and ReBoot, a personal soft exo-suit for home and community use by individuals post-stroke. The company markets and sells its products directly to institutions and individuals, as well as through third-party distributors. The company was formerly known as Argo Medical Technologies Ltd. ReWalk Robotics Ltd. was incorporated in 2001 and is headquartered in Yokneam Illit, Israel.

Key Stats

• Today's Range: $0.58 to $0.60
• 50-Day Range: $0.53 to $0.83
• 52-Week Range: $0.50 to $4.00
• Volume: 295,494 shs
• Average Volume: 256,675 shs
• Market Capitalization: $9.18 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $9.00
• Consensus Rating: Buy

Lifeward Stock Analysis - MarketRank™

Lifeward scored higher than 53% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.5 / 5
• Analyst Rating: Buy

Consensus Rating

Lifeward has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 3 buy ratings, no hold ratings, and no sell ratings.

Upside Potential

Lifeward has a consensus price target of $9.00, representing about 1,438.5% upside from its current price of $0.59.

Amount of Analyst Coverage

Lifeward has received no research coverage in the past 90 days.

Earnings and Valuation

• Score: 1.3 / 5
• Proj. Earnings Growth: Growing

Earnings Growth

Earnings for Lifeward are expected to grow in the coming year, from ($1.78) to ($0.16) per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Lifeward is -0.19, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Lifeward is -0.19, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

Lifeward has a P/B Ratio of 0.27. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

7.92% of the float of Lifeward has been sold short.

Short Interest Ratio / Days to Cover

Lifeward has a short interest ratio ("days to cover") of 1.6, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Lifeward has recently decreased by 0.85%, indicating that investor sentiment is improving.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Lifeward does not currently pay a dividend.

Dividend Growth

Lifeward does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

7.92% of the float of Lifeward has been sold short.

Short Interest Ratio / Days to Cover

Lifeward has a short interest ratio ("days to cover") of 1.6, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Lifeward has recently decreased by 0.85%, indicating that investor sentiment is improving.

News and Social Media

• Score: 2.7 / 5
• News Sentiment: 0.88

News Sentiment

Lifeward has a news sentiment score of 0.88. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Computer and Technology companies.

News Coverage This Week

MarketBeat has tracked 6 news articles for Lifeward this week, compared to 2 articles on an average week.

Search Interest

Only 1 people have searched for LFWD on MarketBeat in the last 30 days. This is a decrease of -67% compared to the previous 30 days.

MarketBeat Follows

3 people have added Lifeward to their MarketBeat watchlist in the last 30 days.

Company Ownership

• Score: 0.8 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, Lifeward insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $1,018.00 in company stock.

Percentage Held by Insiders

Only 2.70% of the stock of Lifeward is held by insiders.

Percentage Held by Institutions

Only 26.76% of the stock of Lifeward is held by institutions.

LFWD Stock Analysis - Frequently Asked Questions

How have LFWD shares performed this year?

Lifeward's stock was trading at $1.73 at the beginning of the year. Since then, LFWD stock has decreased by 66.2% and is now trading at $0.5850.

How were Lifeward's earnings last quarter?

Lifeward Ltd. (NASDAQ:LFWD) announced its quarterly earnings data on Thursday, August, 14th. The company reported ($0.58) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.25) by $0.33. The business earned $5.72 million during the quarter, compared to analysts' expectations of $6.62 million. Lifeward had a negative net margin of 121.80% and a negative trailing twelve-month return on equity of 137.91%.
Read the conference call transcript.

When did Lifeward's stock split?

Lifeward shares reverse split on Friday, March 15th 2024.The 1-7 reverse split was announced on Friday, March 15th 2024. The number of shares owned by shareholders was adjusted after the market closes on Friday, March 15th 2024. An investor that had 100 shares of stock prior to the reverse split would have 14 shares after the split.

Who are Lifeward's major shareholders?

Top institutional shareholders of Lifeward include Group One Trading LLC. Insiders that own company stock include Global Fund Lp Lind II, Michael Swinford, Jeannine Lynch, Joseph E Turk Jr and Michael A Lawless.
View institutional ownership trends.

How do I buy shares of Lifeward?

Shares of LFWD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Lifeward own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Lifeward investors own include Invesco QQQ (QQQ), NVIDIA (NVDA), Broadcom (AVGO), e.l.f. Beauty (ELF), Arista Networks (ANET), Adobe (ADBE) and AppLovin (APP).

Company Calendar

• Last Earnings: 8/14/2025
• Today: 9/14/2025
• Next Earnings (Estimated): 11/11/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Computer and Technology
• Industry: INTERNET SOFTWARE
• Sub-Industry: Medical Equipment
• Current Symbol: NASDAQ:LFWD
• Previous Symbol: NASDAQ:LFWD
• CIK: 1607962
• Web: www.rewalk.com
• Phone: 972-4-959-0123
• Fax: N/A
• Employees: 60
• Year Founded: N/A

Price Target and Rating

• Average Price Target for Lifeward: $9.00
• High Price Target: $13.00
• Low Price Target: $4.00
• Potential Upside/Downside: +1,438.5%
• Consensus Rating: Buy
• Rating Score (0-4): 3.00
• Research Coverage: 3 Analysts

Profitability

• EPS (Trailing Twelve Months): ($3.12)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$28.94 million
• Net Margins: -121.80%
• Pretax Margin: -121.63%
• Return on Equity: -137.91%
• Return on Assets: -90.28%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 2.00
• Quick Ratio: 1.26

Sales & Book Value

• Annual Sales: $25.66 million
• Price / Sales: 0.36
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $2.14 per share
• Price / Book: 0.27

Miscellaneous

• Outstanding Shares: 15,700,000
• Free Float: 15,281,000
• Market Cap: $9.18 million
• Optionable: Optionable
• Beta: 0.16